These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 35215822)

  • 1. Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines.
    Abdel-Bakky MS; Amin E; Ewees MG; Mahmoud NI; Mohammed HA; Altowayan WM; Abdellatif AAH
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation and coagulopathy - an ominous duo in COVID19.
    Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
    Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulopathy of Coronavirus Disease 2019.
    Iba T; Levy JH; Levi M; Connors JM; Thachil J
    Crit Care Med; 2020 Sep; 48(9):1358-1364. PubMed ID: 32467443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Coagulopathy: From Pathogenesis to Treatment.
    Alnima T; Mulder MMG; van Bussel BCT; Ten Cate H
    Acta Haematol; 2022; 145(3):282-296. PubMed ID: 35499460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19-associated coagulopathy: a concise review on pathogenesis and clinical implications.
    Memar Montazerin S; Najafi H; Shojaei F; Chi G; Goudarzi S; Sharfaei S; Kahe F; Hassanzadeh S
    Infez Med; 2021 Mar; 29(1):1-9. PubMed ID: 33664168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19-associated coagulopathy and disseminated intravascular coagulation.
    Asakura H; Ogawa H
    Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases.
    Acanfora D; Acanfora C; Ciccone MM; Scicchitano P; Bortone AS; Uguccioni M; Casucci G
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination.
    Yamada S; Asakura H
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
    Miesbach W; Makris M
    Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematological manifestations of COVID-19: From cytopenia to coagulopathy.
    Agbuduwe C; Basu S
    Eur J Haematol; 2020 Nov; 105(5):540-546. PubMed ID: 32663356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic Complications of COVID-19 Infection: A Review.
    Castro RA; Frishman WH
    Cardiol Rev; 2021; 29(1):43-47. PubMed ID: 32947478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to recognize and manage COVID-19-associated coagulopathy.
    Gerber GF; Chaturvedi S
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):614-620. PubMed ID: 34889412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 induced coagulopathy and potential role of anticoagulation: Scoping review of literature.
    Zehra Naseem ; Khakwani MM; Maaha Ayub ; Ahmed Ayaz ; Bushra Jamil ; Arshad A
    Monaldi Arch Chest Dis; 2022 Jan; 92(4):. PubMed ID: 35086326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 coagulopathy - what should we treat?
    Chowdary P
    Exp Physiol; 2022 Jul; 107(7):749-758. PubMed ID: 35733235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peculiarities of blood coagulation disorders in patients with COVID-19].
    Evtugina NG; Sannikova SS; Peshkova AD; Safiullina SI; Andrianova IA; Tarasova GR; Khabirova AI; Rumyantsev AG; Ataullakhanov FI; Litvinov RI
    Ter Arkh; 2021 Nov; 93(11):1255-1263. PubMed ID: 36286646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution value of coagulation abnormalities in COVID-19 prognosis: a bright perspective on the laboratory pattern of patients with coronavirus disease 2019.
    Sayyadi M; Khosravi M; Ghaznavi-Rad E
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):518-522. PubMed ID: 33506943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of COVID-19 Disease on Platelets and Coagulation.
    Wool GD; Miller JL
    Pathobiology; 2021; 88(1):15-27. PubMed ID: 33049751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people?
    Xu K; Wei Y; Giunta S; Zhou M; Xia S
    Exp Gerontol; 2021 Aug; 151():111423. PubMed ID: 34048906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence.
    Ragnoli B; Da Re B; Galantino A; Kette S; Salotti A; Malerba M
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematological findings and complications of COVID-19.
    Terpos E; Ntanasis-Stathopoulos I; Elalamy I; Kastritis E; Sergentanis TN; Politou M; Psaltopoulou T; Gerotziafas G; Dimopoulos MA
    Am J Hematol; 2020 Jul; 95(7):834-847. PubMed ID: 32282949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.